1. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas orinsulin compared with conventionaltreatment and risk of complications inpatients with type 2 diabetes.  Lancet. 1998; 352:837-53. 2. United Kingdom Prospective Diabetes Study Group. Overview of 6 yearsâ€™ thera-py of type 2 diabetes: a progressive dis-ease. Diabetes.  1995; 44:1249-58. 3. American Diabetes Association. Implica- tions of the United Kingdom ProspectiveDiabetes Study (position statement). Dia- betes Care . 2002; 25(suppl 1):S28-32. 4. Harris MI, Eastman RC, Cowie CC et al. Racial and ethnic differences in glycemiccontrol of adults with type 2 diabetes. Di- abetes Care . 1999; 22:403-8 5. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes. JAMA . 2002; 287:360-72. 6. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med . 1999; 131:281-303. 7. Eng J, Kleinman WA, Singh L et al. Isola-